Aethlon Medical SG&A Expense (Annual) Insights

Aethlon Medical Inc (AEMD)

0.4741 +0.04 (+8.00%) USD | NASDAQ | Sep 27, 16:00

0.4515 -0.02 (-4.77%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2000. Upgrade now.

Date	Value
March 31, 2024	12.64M
March 31, 2023	12.47M
March 31, 2022	10.72M
March 31, 2021	8.551M
March 31, 2020	6.580M
March 31, 2019	6.229M
March 31, 2018	4.981M
March 31, 2017	6.490M
March 31, 2016	5.271M
March 31, 2015	4.755M
March 31, 2014	4.680M
March 31, 2013	4.805M
March 31, 2012	4.474M

Date	Value
March 31, 2011	4.557M
March 31, 2010	2.849M
March 31, 2009	2.923M
March 31, 2008	2.893M
March 31, 2007	2.084M
March 31, 2006	2.013M
March 31, 2005	2.183M
March 31, 2004	0.9955M
March 31, 2003	1.637M
March 31, 2002	2.069M
March 31, 2001	1.866M
March 31, 2000	0.8577M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

6.580M

Minimum

2020

12.64M

Maximum

2024

10.19M

Average

10.72M

Median

2022

SG&A Expense (Annual) Benchmarks